# The Medicines (Products for Human Use) (Fees) Regulations 2016, Paragraph 8: Parallel import licence


The fee payable for an application to vary a parallel import licence shall be waived if the application is made only—
(a) because of a change to the number of an authorisation granted under the provisions of the 2001 Directive by another member State for a product to which the licence relates; and
(b) so that the number of that authorisation shown on the licence can be changed.

---
Source: https://www.legislation.gov.uk/uksi/2016/190/schedule/7/paragraph/8 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/schedule-7/paragraph-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.